Saturn V Capital Management LP
Q2 2025 13F Holdings
- Locationaustin, TX
- Num holdings
24
- Value ($000)
$246,761
- Date Filed08/13/2025
- Form type13F-HR
- CIK0001964437
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q2 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
---|---|---|---|---|---|---|---|
JAZZ PHARMACEUTICALS PLC | SHS USD | G50871105 | $21.96M | 9 % | 206,952 | ||
IRON DISC MEDICINE INC | COM | 254604101 | $20.98M | 9 % | 396,115 | ||
AMLX AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | $20.90M | 9 % | 3,260,570 | ||
PCVX VAXCYTE INC | COM | 92243G108 | $17.69M | 7 % | 544,221 | ||
COGT COGENT BIOSCIENCES INC | COM | 19240Q201 | $16.50M | 7 % | 2,297,524 | ||
CELC CELCUITY INC | COM | 15102K100 | $15.83M | 6 % | 1,185,520 | ||
CGON CG ONCOLOGY INC | COM | 156944100 | $15.25M | 6 % | 586,647 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | $14.66M | 6 % | 468,364 | ||
DYN DYNE THERAPEUTICS INC | COM | 26818M108 | $13.86M | 6 % | 1,455,429 | ||
MLTX MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | $13.73M | 6 % | 290,784 |
Rows Per Page
10
- 10
- 50
- 100